Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – For patients with advanced, untreated non-small-cell lung cancer, the American Society of Clinical Oncology recommends that the tumor be tested for genetic mutations…
NEW YORK (Reuters Health) – The risk of pancreatic malignancy is increased in patients with diabetes, researchers from Taiwan report in a pre-print version of a study that…
NEW YORK (Reuters Health) – Patients with osteogenesis imperfecta face an increased risk of cardiovascular abnormalities, researchers from Norway report in the March American Heart Journal. Osteogenesis imperfecta…
NEW YORK (Reuters Health) – There is some evidence to support the use of immunosuppressive therapy to avoid relapse in inflammatory bowel disease (IBD), but more research is…
NEW YORK (Reuters Health) – Drugs currently available for patients with heart failure with preserved ejection fraction (HFpEF) have no mortality benefit, according to a meta-analysis published in…
NEW YORK (Reuters Health) – When patients with chronic obstructive pulmonary disease (COPD) come down with community-acquired pneumonia, whether or not they use inhaled corticosteroids has no effect…
NEW YORK (Reuters Health) – Eye drops containing lubricants, corticosteroids, cyclosporine, or autologous serum improve dry eye symptoms associated with Sjögren’s syndrome (SS), according to a literature review.…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the importance of taking a holistic approach to AIDS work in Africa. For more information…
Marilyn Mann, OD, of Comprehensive Eye Care in Valley Cottage, NY, interviews Terry Peterson, Senior Sales Executive for Carl Zeiss Meditec, regarding the Cirrus HD-OCT, the most advanced…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…
